CAMP4 Therapeutics Corp. (CAMP)
4.26
-0.07
(-1.62%)
USD |
NASDAQ |
Nov 11, 12:20
CAMP4 Therapeutics Total Assets (Quarterly) : 134.01M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 134.01M |
| June 30, 2026 | 93.43M |
| March 31, 2026 | 105.46M |
| December 31, 2025 | 117.81M |
| September 30, 2025 | 86.40M |
| June 30, 2025 | 51.28M |
| Date | Value |
|---|---|
| March 31, 2025 | 62.77M |
| December 31, 2024 | 78.31M |
| September 30, 2024 | 21.36M |
| June 30, 2024 | 29.94M |
| March 31, 2024 | |
| December 31, 2023 | 54.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
| Vericel Corp. | 517.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.92M |
| Shareholders Equity (Quarterly) | 107.09M |
| Debt to Equity Ratio | 0.0602 |
| Current Ratio | 6.420 |
| Net Debt Paydown Yield | 0.06% |